Cargando…
HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression
Mantle cell lymphoma (MCL) is an especially aggressive and highly heterogeneous mature B-cell lymphoma. Heat shock protein 90 (HSP90) is considered an attractive therapeutic target in a variety of cancers, including MCL, but no HSP90 inhibitors have succeeded in the clinical trials to date. Explorin...
Autores principales: | Liu, Hanqing, Lu, Ziwen, Shi, Xiaofeng, Liu, Lanlan, Zhang, Peishan, Golemis, Erica A., Tu, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363837/ https://www.ncbi.nlm.nih.gov/pubmed/34302809 http://dx.doi.org/10.1016/j.jbc.2021.100996 |
Ejemplares similares
-
HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton’s Tyrosine Kinase Inhibitor Ibrutinib
por: Lu, Ziwen, et al.
Publicado: (2022) -
Transient HSP90 inhibition enhances the sensitivity of mantle cell lymphoma to poly (ADP-ribose) polymerase (PARP) inhibitors
por: Shi, Chaowen, et al.
Publicado: (2023) -
Hsp90 Inhibitors Prevent HSV-1 Replication by Directly Targeting UL42-Hsp90 Complex
por: Qin, Shurong, et al.
Publicado: (2022) -
Downregulation of the evolutionary capacitor Hsp90 is mediated by social cues
por: Peuß, Robert, et al.
Publicado: (2015) -
RAD54B mutations enhance the sensitivity of ovarian cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors
por: Liu, Peng, et al.
Publicado: (2022)